PE/Cyanine7 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_PECy7_090507
C57BL/6 mouse splenocytes stained with 30-F11 PE/Cyanine7
  • 30-F11_PECy7_090507
    C57BL/6 mouse splenocytes stained with 30-F11 PE/Cyanine7
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
103113 25 µg 70€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103114 100 µg 152€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Tran NT, et al. 2019. Cell Rep. 28:3510. PubMed
  2. Garber C, et al. 2019. Nat Neurosci. 1.802777778. PubMed
  3. Dobie R, et al. 2020. Cell Reports. 29(7):1832-1847.e8.. PubMed
  4. Wu JH, et al. 2020. EMBO Mol Med. 12:e10154. PubMed
  5. Rodriguez de la Fuente L, et al. 2021. STAR Protoc. 2:100841. PubMed
  6. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  7. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  8. Yang AC, et al. 2020. Nature. 583:425. PubMed
  9. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  10. Khare A, et al. 2016. Cell Rep. 15: 1700-1714. PubMed
  11. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  12. Shi Y, et al. 2020. Med Sci Monit. 26:e923328. PubMed
  13. Smith NR, et al. 2017. Cell Mol Gastroenterol Hepatol. 0.395138889. PubMed
  14. Zhou J, et al. 2019. Immunity. 50:403. PubMed
  15. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  16. Chang T, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006485. PubMed
  17. Kim SS, et al. 2022. Cancers (Basel). 14:. PubMed
  18. García-Prat L, et al. 2020. Nat Cell Biol. 22:1307. PubMed
  19. Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed
  20. Pan J, et al. 2021. Mol Ther Nucleic Acids. 26:970. PubMed
  21. Helms EJ, et al. 2021. Cancer Discov. Online ahead of print. PubMed
  22. Huck NA, et al. 2021. J Neurosci. 41:4349. PubMed
  23. Wu Q, et al. 2021. Cancer Commun (Lond). Online ahead of prin. PubMed
  24. Ma Q, et al. 2021. Clin Transl Immunology. 10:e1300. PubMed
  25. Yagishita Y, et al. 2020. Cell Mol Gastroenterol Hepatol. . PubMed
  26. Wiesner DL, et al. 2020. Cell Host Microbe. 614:27. PubMed
  27. Wagner G, et al. 2017. Sci Rep. 7:40881. PubMed
  28. Weeden C, et al. 2017. PLoS Biol. 10.1371/journal.pbio.2000731. PubMed
  29. Hilliard K, et al. 2015. Infect Immun . 83: 4015 - 4027. PubMed
  30. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  31. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  32. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  33. Mansouri N, et al. 2019. JCI Insight. 4:e128060. PubMed
  34. Kim YS, et al. 2021. Cell Death Dis. 12:307. PubMed
  35. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  36. Manivasagam S, et al. 2022. J Immunol. 208:1341. PubMed
  37. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  38. Vila Ellis L, et al. 2020. Dev Cell. 617:52. PubMed
  39. Han Y, et al. 2020. Nat Commun. 11:1776. PubMed
  40. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  41. White MPJ, et al. 2020. Front Immunol. 11:1830. PubMed
  42. Saito S, et al. 2020. Nutrients. 12:. PubMed
  43. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  44. Wang B, et al. 2017. EBioMedicine. 10.1016/j.ebiom.2017.03.041. PubMed
  45. Kaczmarek–Hájek K, et al. 2018. Elife. 7:e36217. PubMed
  46. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  47. Ohigashi I, et al. 2020. Cell Reports. 29(9):2901-2916.e6.. PubMed
  48. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  49. Kobayashi H, et al. 2020. STAR Protoc. 1:100078. PubMed
  50. Little DR, et al. 2021. Nat Commun. 12:2509. PubMed
  51. Bhopale VM, et al. 2021. J Appl Physiol (1985). 130:1604. PubMed
  52. Zheng L, et al. 2022. J Neuroinflammation. 19:128. PubMed
  53. Mathews J, et al. 2014. PLoS One. 9:97707. PubMed
  54. Britschgi A, et al. 2017. Nature. 541:541-545. PubMed
  55. Valds-Mora F, et al. 2021. Cell Reports. 35(2):108945. PubMed
  56. DellOrso S, et al. 2021. STAR Protocols. 2(2):100451. PubMed
  57. Pan J, et al. 2020. J Neuroinflammation. 17:97. PubMed
  58. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  59. Garber C, et al. 2018. Nat Immunol. 19:151. PubMed
  60. Campanario S, et al. 2021. Front Cell Dev Biol. 8:620409. PubMed
  61. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  62. Jiang YH, et al. 2020. J Mol Cell Cardiol. 138:115. PubMed
  63. Wang B,et al. 2017. Cell Discov.. 10.1038/celldisc.2017.36. PubMed
  64. Solanas G, et al. 2017. Cell. 170:678. PubMed
  65. Dubey LK, et al. 2019. Cell Rep. 27:2442. PubMed
  66. Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
  67. Galvão I, et al. 2018. Front Immunol. 9:142. PubMed
  68. Mizuochi C, et al. 2012. PLoS One. 7:e35763. PubMed
  69. Gigliotti J, et al. 2013. J Am Soc Nephrol. 24:1451. PubMed
  70. Bahar Halpern K, et al. 2020. Nat Commun. 11:1936. PubMed
  71. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  72. Gu H, et al. 2018. Aging (Albany NY). 1.525694444. PubMed
  73. McGowan SE, et al. 2018. Am J Physiol Lung Cell Mol Physiol. 315:L102. PubMed
  74. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  75. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  76. Yang R, et al. 2022. Front Pharmacol. 13:774440. PubMed
  77. Fix DK, et al. 2021. Aging Cell. 20:e13448. PubMed
  78. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  79. Zhu L, et al. 2021. Stem Cell Res Ther. 12:408. PubMed
  80. Onder L et al. 2017. Immunity. 47(1):80-92 . PubMed
  81. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  82. Kimbrough D, et al. 2018. J Mol Cell Cardiol. 119:51. PubMed
  83. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  84. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  85. Wang W, et al. 2020. Immunity. 51(6):1102-1118.e7.. PubMed
  86. Huang CH, et al. 2020. Adv Ther (Weinh). 3:. PubMed
  87. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  88. Okamura T, et al. 2021. Front Immunol. 12:669629. PubMed
  89. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  90. Basu A, et al. 2021. Cancer Immunol Res. Online ahead of print. PubMed
  91. Fennell LM, et al. 2020. EMBO J. 39:e103303. PubMed
  92. Allen S, et al. 2011. J Virol. 85:11448. PubMed
  93. Jaworska K, et al. 2015. J Immunol. 194:325. PubMed
  94. Furuya Y, et al. 2015. PLoS Pathog. 11: 1005180. PubMed
  95. Gomzikova MO, et al. 2020. Sci Rep. 10:10740. PubMed
  96. Cain MP, et al. 2020. Dis Model Mech. 13:00. PubMed
  97. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  98. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  99. Yen Y, et al. 2008. J Virol. 82:12312. PubMed
  100. Uribesalgo I, et al. 2019. EMBO Mol Med. 11:e9266. PubMed
  101. Son NH, et al. 2018. J Clin Invest. 128:4329. PubMed
  102. Ellegast JM, et al. 2022. Cancer Discov. 12:1760. PubMed
  103. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  104. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  105. Manco R, et al. 2021. Nat Commun. 12:3074. PubMed
  106. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  107. Berg AL, et al. 2022. Cancers (Basel). 14:. PubMed
  108. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  109. McCoy S 2015. Am J Physiol Lung Cell Mol Physiol. 309: L463-L474. PubMed
  110. Kellish P, et al. 2019. J Clin Invest. 130:2279. PubMed
  111. Magri G et al. 2017. Immunity. 47(1):118-134 . PubMed
  112. Sela Y, et al. 2021. Elife. 10: . PubMed
  113. Ishii H, et al. 2012. Cell Death Dis. 9;3:e363. PubMed
  114. Wang F, et al. 2021. Cell. 184(2):422-440.e17. PubMed
  115. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  116. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  117. Pascual G, et al. 2021. Nature. 599:485. PubMed
  118. Kolodziejczyk AA, et al. 2020. Nat Med. 26:1899. PubMed
  119. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  120. Chu X, et al. 2021. Front Cell Dev Biol. 9:671841. PubMed
  121. Shafiei-Jahani P, et al. 2021. Nat Commun. 12:2526. PubMed
  122. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  123. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  124. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  125. Kobayashi H, et al. 2020. Cell Reports. 28(1):145-158.e9.. PubMed
  126. Merrell AJ, et al. 2021. Hepatology. 74:444. PubMed
  127. Jin L, et al. 2022. J Immunol Res. 2022:7222638. PubMed
  128. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  129. Evgin L, et al. 2022. Sci Transl Med. 14:eabn2231. PubMed
  130. Wu X, et al. 2016. Sci Rep. 6:18685. PubMed
  131. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  132. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  133. van Gastel N, et al. 2020. Cell Metabolism. 32(3):391-403.e6. PubMed
  134. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
  135. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  136. Zhu J, et al. 2021. Cancer Cell Int. 21:529. PubMed
  137. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  138. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  139. Li J, et al. 2020. Development. :. PubMed
  140. Tang Z, et al. 2021. Stem Cell Res Ther. 12:397. PubMed
  141. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  142. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  143. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  144. Mohammadpour H, et al. 2021. Cell Rep. 37:109883. PubMed
  145. Zhu S, et al. 2022. EBioMedicine. 80:104060. PubMed
  146. Sung PS, et al. 2022. JCI Insight. :. PubMed
  147. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  148. Magness S, et al. 2013. Am J Physiol Gastrointest Liver Physiol. 305:542. PubMed
  149. Wang W, et al. 2021. STAR Protocols. 2(3):100756. PubMed
  150. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  151. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  152. Smith NR, et al. 2018. Cell Mol Gastroenterol Hepatol. 6:79. PubMed
  153. Zhu K, et al. 2022. EMBO Rep. 23:e54499. PubMed
  154. Nian Z, et al. 2021. Clin Cancer Res. 27:6026. PubMed
  155. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  156. Hakim R, et al. 2021. J Neurosci. 41:8441. PubMed
  157. Ognjenovic NB, et al. 2020. Dev Cell. 55:544. PubMed
  158. Gu H, et al. 2021. Elife. 10:. PubMed
  159. Hendee K, et al. 2021. Aging (Albany NY). 13:7781. PubMed
  160. Issah Y, et al. 2021. Elife. 10:. PubMed
  161. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  162. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  163. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  164. Fan X, et al. 2020. Acta Physiol (Oxf). 230:e13475. PubMed
  165. Fang Y, et al. 2022. Development. 149:. PubMed
  166. Boyce M, et al. 2022. Cells. 11:. PubMed
  167. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  168. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  169. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  170. Béchade C, et al. 2020. Glia. . PubMed
  171. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  172. Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
  173. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  174. Piirainen S, et al. 2021. Glia. 69:2459. PubMed
  175. Li Q, et al. 2022. J Biol Chem. :101753. PubMed
  176. Dong H, et al. 2022. Nat Metab. 4:90. PubMed
  177. Andreou T, et al. 2021. J Immunother Cancer. 9:. PubMed
  178. Rochford I, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 321:L686. PubMed
  179. Sheng J, et al. 2021. eLife. 10:00. PubMed
  180. Moreno M et al. 2014. The Journal of Neuroscience. 34(24):8175-85 . PubMed
  181. Ghosh S, et al. 2019. Commun Biol. 0.325. PubMed
  182. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  183. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  184. Hussein M, et al. 2015. PLoS One. 10: 0135218. PubMed
  185. Gigliotti J, et al. 2015. J Am Soc Nephrol. 26: 2470 - 2481. PubMed
  186. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  187. Gerner-Mauro KN, et al. 2020. Proc Natl Acad Sci U S A. 117:12182. PubMed
  188. Kimmel JC, et al. 2021. Cell Reports. 35(4):109046. PubMed
  189. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  190. Wu H, et al. 2020. Cell. 180(1):107-121.e17.. PubMed
  191. Muri J, et al. 2020. Cell Reports. 30(13):4399-4417. PubMed
  192. Chithanathan K, et al. 2022. Biology (Basel). 11:. PubMed
  193. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  194. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  195. Song X, et al. 2021. FEBS Open Bio. 11:2453. PubMed
  196. Ren X, et al. 2021. Cell Death Dis. 12:484. PubMed
RRID
AB_312978 (BioLegend Cat. No. 103113)
AB_312979 (BioLegend Cat. No. 103114)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV™ 395 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05-14-2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account